概括
低剂量肝素预防可显著减少大手术后静脉血栓形成. 虽然轻微出血略有增加,但治疗耐受性良好,有效预防深静脉血栓形成.
科学领域:
- 血管外科 血管外科
- 进行血栓预防治疗.
- 药理学 药理学是指药理学的学科.
背景情况:
- 静脉血栓塞栓症 (VTE) 是重大选择性手术后的一个重大风险.
- 有效的预防策略对于减少静脉瘤发病率和相关发病率至关重要.
- 低剂量肝素已被研究为预防剂,但其精确的影响需要继续评估.
研究的目的:
- 评估低剂量肝素预防在进行重大选择性手术后预防静脉血栓形成 (VT) 的有效性.
- 评估与低剂量肝素预防相关的出血并发症的发生率.
- 为了确定这一预防方案的整体安全性和耐受性.
主要方法:
- 一项前性对照性研究,涉及820名接受重大选择性手术的患者.
- 使用放射性 (125I) 标记的纤维素原体进行腿部扫描检测静脉血栓.
- 在赫巴林治疗组和对照组之间比较VTE发生率和出血事件.
主要成果:
- 总体静脉瘤发病率从对照组的16.0%下降到接受赫巴林治疗的患者中的4.2%.
- 脊柱或股骨静脉血栓的发生率从2.9%降至1.0%.
- 观察到轻微出血的轻微增加 (伤口血液瘤,输血量,血红素下降),但在临床上无意义.
结论:
- 低剂量肝素预防在减少大选手术后静脉血栓形成方面非常有效.
- 观察到的出血并发症的增加是轻微的,并没有超过VTE预防的好处.
- 肝素预防药物耐受性很好,在这种患者群体中代表了预防静脉瘤的安全和有益的策略.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...


